Net profit of Gujarat Inject (Kerala) rose 300.00% to Rs 0.04 crore in the quarter ended March 2024 as against Rs 0.01 crore during the previous quarter ended March 2023. Sales reported to Rs 5.42 crore in the quarter ended March 2024. There were no Sales reported during the previous quarter ended March 2023.For the full year,net profit rose 100.00% to Rs 0.08 crore in the year ended March 2024 as against Rs 0.04 crore during the previous year ended March 2023. Sales rose 3305.88% to Rs 5.79 crore in the year ended March 2024 as against Rs 0.17 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales5.420 0 5.790.17 3306 OPM %0.920 -0.69-223.53 - PBDT0.050.01 400 0.100.05 100 PBT0.050.01 400 0.100.05 100 NP0.040.01 300 0.080.04 100 Powered by Capital Market - Live News

Gujarat Inject (Kerala) will hold a meeting of the Board of Directors of the Company on 9 May 2024.Powered by Capital Market - Live News

Gujarat Inject (Kerala) reported no net profit/loss in the quarter ended December 2023 and during the previous quarter ended December 2022. Sales rose 120.00% to Rs 0.22 crore in the quarter ended December 2023 as against Rs 0.10 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales0.220.10 120 OPM %-18.180 - PBDT00 0 PBT00 0 NP00 0 Powered by Capital Market - Live News

Gujarat Inject (Kerala) will hold a meeting of the Board of Directors of the Company on 13 February 2024.Powered by Capital Market - Live News

Gujarat Inject (Kerala) announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 20 January 2024 .Powered by Capital Market - Live News